Finance

Results: 3361-3372 of 44123

Validus Announces Liquidity-at-Risk Analytics Enhancement to Its Horizon™ Platform

Morningstar Reaches New Milestone in the CRSP Acquisition, Rebranding CRSP Market Indexes to Morningstar Indexes

Beacon Therapeutics Annouces Presentations at the ARVO 2026 Annual Meeting

SS&C Unveils WorkHQ to Power Enterprise Agentic Automation

Ecolab Life Sciences Expands Global Bioprocessing Capabilities With New Advanced Development and Applications Center in Korea

• Chiesi agreed to acquire KalVista Pharmaceuticals for $27.00 per share in cash, representing an equity consideration of approximately $1.9bn • Acquisition adds to Chiesi’s rare immunology portfolio the first oral, on-demand therapy for hereditary angioedema, strengthening Chiesi’s long-term commitment to people living with rare conditions • Transaction expected to close in Q3 2026

Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio

LTS Expands CDMO Portfolio with Ophthalmic Drug Delivery Solutions

PR Newswire associated0

ESG | HitGen Releases 2025 Sustainability Report

ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results

PR Newswire associated0

STARTRADER Transforms Basketball Court for 10,000 Youth Annually in Vietnam

The 9th Digital China Summit opens in Fuzhou, Fujian Province

PR Newswire associated0

In Xi'an, Mayors from Around the World Explore Pathways for Silk Road Cities to Balance Ancient Heritage with Modern Industry